Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
about
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral BloodEnrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceClassification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns.Protein expression patterns in primary carcinoma of the vagina.Proteomics of breast cancer: outcomes and prospects.Rapid isolation of phage displayed antibodies to beta-actin eluted from two-dimensional electrophoresis gel.Aberrant expression of RAB1A in human tongue cancer.Proteomics of breast cancer: principles and potential clinical applications.Proteomic analysis of estrogen response of premalignant human breast cells using a 2-D liquid separation/mass mapping technique.Classifications of ovarian cancer tissues by proteomic patterns.The human TPR protein TTC4 is a putative Hsp90 co-chaperone which interacts with CDC6 and shows alterations in transformed cells.Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.Proteomics: a new approach to the study of disease.Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.Breast cancer: when proteomics challenges biological complexity.Proteomics in biomarker discovery and drug development.Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction methodThe potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.Proteomics of TGF-beta signaling and its impact on breast cancer.Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.Apoptosis-induced cleavage of keratin 15 and keratin 17 in a human breast epithelial cell line.Ras- and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent.Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines.A two-dimensional electrophoresis database of human breast epithelial cell proteins.Analysis of constant tissue remodeling in Syrian hamster Harderian gland: intra-tubular and inter-tubular syncytial masses.Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology.
P2860
Q24597444-8DEB3B1F-553C-4BF7-B295-1BE371280B86Q24806218-5F6D8985-F30D-4284-8CB7-372B8453ACECQ30595087-96FF5287-20F2-4143-B7E9-5E68BABE95F0Q30763429-F2F24A18-BAF5-4E19-BBBD-B11AB30C1048Q30893442-BF544923-01C9-46F6-9330-E402E767AD8FQ32033028-6EE38C8C-C46A-4569-B6EB-1F9579F79D43Q33214689-0A8DE329-106F-468A-BD70-5F195DB02AA3Q33245053-2EF9DA57-B24C-44AD-B11F-961685D7C5E2Q33246456-6050B6FF-3DBB-46A7-8387-21C96ACC5AEDQ33261768-EB0E5007-3302-489C-914B-6334A643C674Q33322509-99CB7FE5-1360-4142-B7B3-06B7A9A35CFFQ34020013-A863C6F0-3976-46E5-BB94-C976087D8220Q34071926-F0C4F36F-03EE-463F-AAAC-7EFBC1EABA55Q34085928-1D37A9AA-CB94-4F1F-8263-0693AE18EB59Q35140561-315FC0C5-6AF5-4A5B-B721-4FE7D70A45E6Q35182541-B35A047A-A875-4A4A-8819-A4B07D2EE3D3Q35790106-951DA692-F999-4B60-BAEC-D4C9EC411FFAQ35854460-92064BDE-77D9-4A2B-9DFA-2AC3D44C2D5FQ36322164-850E5752-4A7F-45D6-8973-B058DE449903Q36546865-20FDC9A9-DFEF-4487-873B-752D4376C6CAQ37137019-0C162F2C-6BC5-43D2-96D6-48D9B2439E02Q38456584-BC1E05E0-DA6D-4E66-A541-1B7FF75CDDB9Q39044601-D8CE1255-F904-4EC3-9E94-8047C1BCF2F1Q40626451-E4318A44-5855-4B89-8448-8C7D5D7DD6EAQ40810341-E2B29C81-188F-4A42-AD41-0A11B55CF308Q40993730-62E7082F-9CC1-4EA3-B58C-8FD79C13E399Q41050442-B2E8C41F-8938-4810-A35A-36B73D03AF8EQ41122049-414D2BD1-D49C-4790-BC7B-23AF3C4FE920Q42435752-4CDAF910-C3CE-404F-9D6C-F3D583CE3DB9Q51507853-A174888B-6546-4F2E-B8FC-CFB5309BA1EDQ53898691-D774EAC2-C876-41F0-BCFE-7ABCFE222669
P2860
Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@ast
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@en
type
label
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@ast
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@en
prefLabel
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@ast
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@en
P2093
P2860
P356
P1476
Analysis of polypeptide expres ...... wn-regulation of cytokeratins.
@en
P2093
Eriksson E
P2860
P2888
P304
P356
10.1038/BJC.1996.600
P407
P577
1996-11-01T00:00:00Z